Gout News

The FDA has approved an updated label for Gloperba, an oral liquid colchicine formulation, allowing for precision dosing, according to a press release from Scilex Holding Company.

The total number of patients with gout across the world is estimated to increase more than 70% from 2020 to 2050, largely due to aging and population growth, according to forecasting model data published in The Lancet Rheumatology.

Individuals who follow a diet of healthy plant foods demonstrate a lower risk for gout, while those with a greater intake of unhealthy plant foods had a higher risk, according to data published in JAMA Network Open.

When initiating allopurinol for gout under a “start low, go slow” dosing strategy, flares in the first 6 months are most common in patients starting with 100 mg daily, or who flared in the month before beginning therapy, according to data.

Nearly half of patients with gout achieved remission with pegloticase treatment by 52 weeks, indicating longer-term benefits for intensive urate-lowering therapy, according to data presented at EULAR 2024 Congress.

The ability to view laboratory results, track symptoms and sharing them with a provider were rated as the most useful potential app functions by patients with rheumatic and musculoskeletal diseases, according to data.

Patients with atherosclerosis and elevated LDL plus autoimmune or inflammatory disease may derive particular CV benefit from PCSK9 inhibition with evolocumab, a speaker reported.

A nurse-led gout care program nearly doubled the rate of patients achieving low plasma urate levels and resulted in greater continuance of urate-lowering therapy vs. general practice care, according to data published in RMD Open.

A healthy plant-based diet can help mitigate gout risk, especially for women, according to the results of research published in JAMA Network Open.